Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zostavax
Pharma
Merck notched a major win in its Zostavax litigation
Merck is formally bidding adieu to more than 1,000 lawsuits claiming Zostavax causes shingles.
Fraiser Kansteiner
Dec 8, 2022 9:56am
Merck gets a bellwether case win for shingles vaccine Zostavax
Jul 8, 2021 2:55pm
Senators demand more from GSK to boost Shingrix supply
Jul 6, 2018 8:38am
High demand for Shingrix causes supply constraints
Jun 21, 2018 12:13pm
Vaccination rates, RSV vaccine and more—News of Note
Jun 20, 2018 9:25am
Doctors worry Shingrix side effects will put patients off their 2nd dose
Jun 20, 2018 9:15am